Unveiling the Power of VGL101: Vigil Neuroscience’s Groundbreaking Preclinical Findings for ALS and Alzheimer’s

Vigil Neuroscience Presents Preclinical Data on VGL101 for Adult-Onset Neurodegenerative Diseases CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today presented two posters at the Alzheimer’s Association International Conference (AAIC) in San Diego….

Read More

Get Ready to Ride the Ethereum Mega Bull Run – It’s Happening, and It’s Epic!

Are Ethereum Bulls Ready to Take On Bitcoin? Could ETH Overtake BTC as the Best-Performing Asset? Insights into Ethereum’s Potential Rally While the recent Bitcoin and crypto momentum is cooling off, Ethereum (ETH) rejects lower lows, especially against Bitcoin (BTC). Taking to X on December 8, decentralized finance (DeFi) researcher DefiIgnas shared insights that suggest…

Read More

Important Reminder for Investors of PACS Group Inc.: Deadline Approaching for Securities Fraud Class Action Lawsuit

The Impact of the Securities Class Action Lawsuit Against PACS Group, Inc. Background In December 2024, the law firm of Kessler Topaz Meltzer & Check, LLP announced that a securities class action lawsuit has been filed against PACS Group, Inc. The lawsuit, filed in the United States District Court for the Southern District of New…

Read More